BioSpace News Archive

Stereotaxis and Baptist Health Lexington announced that physicians have built upon their two-decades of leadership in robotic heart care with the successful treatment of first patients using the newest advancement in the technology, the Genesis Robotic Magnetic Navigation System.

Hurdle, a pioneer in diagnostic testing, and the Consumer Health division of Bayer have launched a strategic partnership to advance consumer innovations in the emerging area of healthy aging.

Committed to supporting research vital to the field of spinal care, DISC Surgery Center at Newport Beach (“DISC”) has announced its participation in a clinical study on artificial disc replacement and is now enrolling qualified patients.

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) (“NeuroSense”), a company developing treatments for severe neurodegenerative diseases, today reported its financial results for the nine months ended September 30, 2023 and provided a business update.

Shotel Medical today announced its Shotel™ Ankle Arthrodesis Nail System, which uses a novel device design to treat end-stage ankle arthritis.

VIVUS LLC announced positive topline data from a post-marketing study to evaluate the effect of QSYMIA® on 24-hour ambulatory blood pressure .

bioAffinity Technologies, Inc. announced that David Elzi, Ph.D., bioAffinity Technologies Vice President of Research, has been named to the Membership Committee of the American Society for Cell Biology.

Charles River Laboratories International, Inc. (NYSE: CRL) and Genetic Cures for Kids Inc today announced a plasmid DNA contract development and manufacturing organization (CDMO) collaboration.

KORU Medical Systems, Inc. today announced it will host an investor day at the Mahwah, NJ headquarters on Tuesday, December 5, 2023, from 10:00 a.m. to 12:00 p.m. Eastern Time.

SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, today announced successful results from a pre-clinical trial performed by Professor Joseph Tam from The Hebrew University of Jerusalem.